Active ingredientBeloranibCat. No. P-B019-001CAS 251111-30-5Family · Pharmaceutical analytical standards
Beloranib
A fumagillin analogue that inhibits the enzyme MetAP2: born as an anticancer candidate able to curb the growth of new blood vessels, in the 2010s it was studied for obesity and Prader-Willi syndrome, and its development was stopped in 2016. This family brings together the active ingredient.
Did you know?It descends from fumagillin, an antibiotic isolated in 1949 from the mould Aspergillus fumigatus and used in beehives against Nosema apis, a honeybee parasite.
Go to the active ingredient →Active ingredientBeloranibCat. No. P-B019-001CAS 251111-30-5
Active ingredientBeloranib HemioxalateCat. No. P-B019-002CAS 529511-79-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.